Showing results (1391-1400 of 1,653) with videos related to

Sort By:
Pageof 166
Advances in Therapy|October 20, 2006
Delayed P300 latency correlates with abnormal Test of Variables of Attention (TOVA) in adults and predicts early cognitive decline in a clinical settingEric R Braverman, Thomas J H Chen, John Schoolfield, et al.
Stem Cells (Dayton, Ohio)|July 29, 2025
Loss of peroxisome function promotes oxidative stress induced hematopoiesisEmma A Schindhelm, Amada Blake, Megan M Constans, et al.
Age (Dordrecht, Netherlands)|May 9, 2009
Plasma growth hormones, P300 event-related potential and test of variables of attention (TOVA) are important neuroendocrinological predictors of early cognitive decline in a clinical setting: evidence supported by structural equation modeling (SEM) parameter estimatesEric R Braverman, Thomas J H Chen, Thomas J Prihoda, et al.
Advances in Therapy|July 19, 2008
The H-Wave device is an effective and safe non-pharmacological analgesic for chronic pain: a meta-analysisKenneth Blum, Amanda L C Chen, Thomas J H Chen, et al.
International Journal of Environmental Research and Public Health|September 28, 2021
Hypothesizing Nutrigenomic-Based Precision Anti-Obesity Treatment and Prophylaxis: Should We Be Targeting Sarcopenia Induced Brain Dysfunction?Kenneth Blum, Mark S Gold, Luis Llanos-Gomez, et al.
The Journal of Clinical Endocrinology and Metabolism|June 6, 2003
Role for inner ring deiodination preventing transcutaneous passage of thyroxineFerruccio Santini, Paolo Vitti, Luca Chiovato, et al.
Nature|June 4, 2025
Observation of string breaking on a (2 + 1)D Rydberg quantum simulatorDaniel González-Cuadra, Majd Hamdan, Torsten V Zache, et al.
Cases Journal|February 26, 2010
Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE(R) device therapy: a case seriesKenneth Blum, Amanda Lh Chen, Thomas Jh Chen, et al.
Menopause (New York, N.Y.)|November 14, 2007
Effect of estrogen therapy for 1 year on thyroid volume and thyroid nodules in postmenopausal womenGraziano Ceresini, Bruna Milli, Simonetta Morganti, et al.
Muscle & Nerve|May 7, 2021
A phase Ib/IIa, open-label, multiple ascending-dose trial of domagrozumab in fukutin-related protein limb-girdle muscular dystrophyDoris G Leung, Alex E Bocchieri, Shivani Ahlawat, et al.
Pageof 166